Insulin Glargine (Insulin glargine-yfgn) Injection, 3mL prefilled pens, packaged in cartons of five pens, NDC number 49502-394-75, batch number BF21002895, expires August 2023.

Depending on the pharmacy, Semglee injector pens cost about $150 to $190 without insurance for a typical month's supply, compared to $340 to $520 for the same supply of Lantus. Insulin prices have ...

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday.

Meeting Coverage > ADA Biosimilar Insulin Glargine Matches Up With Lantus in Phase III — Merck's copycat has similar HbA1c effect in trial. by Parker Brown, Staff Writer, MedPage Today June 14, 2016 ...

Sanofi SNY announced up to a 78% cut in the list price of its most popular insulin, Lantus, following the likes of rival Novo Nordisk NVO and Eli Lilly LLY.Similar to Lilly, Sanofi also said it is ...

Sanofi announced that the Food and Drug Administration (FDA) has approved once-daily Toujeo (insulin glargine [rDNA origin]) injection 300 U/mL to improve glycemic control in adults with type 1 ...